Skip to main content
NVDA-1.38%AAPL+0.39%GOOGL-2.28%MSFT-0.70%AMZN-0.68%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.31%TSLA-2.02%SKHY+7.05%MU-2.75%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.71%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.36%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.41%AUDJPY-1.70%CHFJPY-1.62%NZDCAD-1.32%EURJPY-1.26%NZDUSD-1.26%GBPJPY-1.25%EURNZD+1.20%USDJPY-1.18%GBPNZD+1.17%CADJPY-1.10%USDZAR+0.84%NZDCHF-0.82%USDNOK+0.79%AUDNZD+0.74%USDSEK+0.70%AUDCAD-0.62%USDTHB+0.61%EURZAR+0.60%EURNOK+0.54%GBPZAR+0.54%AUDUSD-0.51%CADCHF+0.50%USDPLN+0.49%AUDSGD-0.48%USDMXN+0.48%AUDDKK-0.47%EURSEK+0.46%USDCHF+0.46%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%CHFNOK+0.39%EURCHF+0.36%GBPCHF+0.36%GBPHKD+0.32%SGDJPY+0.32%CHFSEK+0.31%NZDSGD-0.29%GBPMXN-0.28%EURHKD-0.26%USDDKK+0.25%USDSGD+0.24%EURPLN+0.24%NOKJPY-0.23%EURCNH-0.17%GBPCAD-0.16%USDILS+0.16%CHFSGD-0.16%EURCAD-0.15%USDTRY+0.11%EURUSD-0.08%GBPSGD-0.07%GBPUSD-0.07%PLNJPY+0.07%AUDCHF-0.07%NZDMXN-0.07%AUDNOK+0.06%USDCAD-0.06%USDCNH+0.06%USDCOP-0.04%EURCZK-0.02%EURGBP+0.02%EURSGD-0.01%USDHKD0.00%EURDKK0.00%GAGUSD-4.64%XAGUSD-4.64%XPTUSD-4.57%HG1-4.04%USOIL+3.43%UKOIL+3.26%COFFEE-2.23%XAUUSD-1.35%GAUUSD-1.34%SUGAR+0.65%XNGUSD-0.57%COTTON+0.32%BTCUSD-1.62%ETHUSD-1.43%USDTUSD-0.03%XRPUSD-2.04%SOLUSD-1.76%TRXUSDT+0.12%ZECUSDT-2.70%DOGEUSD-1.89%XMRUSDT-1.95%LINKUSD-1.00%XLMUSD-1.69%BCHUSDT-4.03%LTCUSD-2.05%UNIUSD-3.20%TONUSD+24.88%HBARUSDT-2.15%SUIUSD-2.13%TAOUSDT-3.31%AAVEUSD-2.63%DOTUSDT-2.36%ICPUSDT-1.44%ONDOUSDT-2.70%WLDUSDT-1.71%ATOMUSDT-2.97%ARBUSDT-0.78%JUPUSDT-3.39%INJUSDT-3.40%STXUSDT-3.80%FETUSDT-3.12%TIAUSDT-1.13%PYTHUSDT-1.61%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-4.03%OPUSDT-1.99%POLUSDT-6.46%IOTAUSDT-4.02%AXSUSDT-2.57%FARTCOINUSDT-4.23%EOSUSDT-0.31%DYDXUSDT-0.53%ORDIUSDT-0.40%GALAUSDT-4.21%NOTUSDT-0.68%RONINUSDT-1.67%NVDA-1.38%AAPL+0.39%GOOGL-2.28%MSFT-0.70%AMZN-0.68%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.31%TSLA-2.02%SKHY+7.05%MU-2.75%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.71%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.36%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.41%AUDJPY-1.70%CHFJPY-1.62%NZDCAD-1.32%EURJPY-1.26%NZDUSD-1.26%GBPJPY-1.25%EURNZD+1.20%USDJPY-1.18%GBPNZD+1.17%CADJPY-1.10%USDZAR+0.84%NZDCHF-0.82%USDNOK+0.79%AUDNZD+0.74%USDSEK+0.70%AUDCAD-0.62%USDTHB+0.61%EURZAR+0.60%EURNOK+0.54%GBPZAR+0.54%AUDUSD-0.51%CADCHF+0.50%USDPLN+0.49%AUDSGD-0.48%USDMXN+0.48%AUDDKK-0.47%EURSEK+0.46%USDCHF+0.46%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%CHFNOK+0.39%EURCHF+0.36%GBPCHF+0.36%GBPHKD+0.32%SGDJPY+0.32%CHFSEK+0.31%NZDSGD-0.29%GBPMXN-0.28%EURHKD-0.26%USDDKK+0.25%USDSGD+0.24%EURPLN+0.24%NOKJPY-0.23%EURCNH-0.17%GBPCAD-0.16%USDILS+0.16%CHFSGD-0.16%EURCAD-0.15%USDTRY+0.11%EURUSD-0.08%GBPSGD-0.07%GBPUSD-0.07%PLNJPY+0.07%AUDCHF-0.07%NZDMXN-0.07%AUDNOK+0.06%USDCAD-0.06%USDCNH+0.06%USDCOP-0.04%EURCZK-0.02%EURGBP+0.02%EURSGD-0.01%USDHKD0.00%EURDKK0.00%GAGUSD-4.64%XAGUSD-4.64%XPTUSD-4.57%HG1-4.04%USOIL+3.43%UKOIL+3.26%COFFEE-2.23%XAUUSD-1.35%GAUUSD-1.34%SUGAR+0.65%XNGUSD-0.57%COTTON+0.32%BTCUSD-1.62%ETHUSD-1.43%USDTUSD-0.03%XRPUSD-2.04%SOLUSD-1.76%TRXUSDT+0.12%ZECUSDT-2.70%DOGEUSD-1.89%XMRUSDT-1.95%LINKUSD-1.00%XLMUSD-1.69%BCHUSDT-4.03%LTCUSD-2.05%UNIUSD-3.20%TONUSD+24.88%HBARUSDT-2.15%SUIUSD-2.13%TAOUSDT-3.31%AAVEUSD-2.63%DOTUSDT-2.36%ICPUSDT-1.44%ONDOUSDT-2.70%WLDUSDT-1.71%ATOMUSDT-2.97%ARBUSDT-0.78%JUPUSDT-3.39%INJUSDT-3.40%STXUSDT-3.80%FETUSDT-3.12%TIAUSDT-1.13%PYTHUSDT-1.61%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-4.03%OPUSDT-1.99%POLUSDT-6.46%IOTAUSDT-4.02%AXSUSDT-2.57%FARTCOINUSDT-4.23%EOSUSDT-0.31%DYDXUSDT-0.53%ORDIUSDT-0.40%GALAUSDT-4.21%NOTUSDT-0.68%RONINUSDT-1.67%
GR

GRAIL Inc. (GRAL)

NASDAQ • Healthcare

$77.48
-$1.61 (-2.0%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$78.96
Day Range$76.99 - $81.18
Avg. Volume (3M)612K
Market Cap$3.3B
52 Week Range
$35.43$118.84
Next EarningsIn 62 daysNov 11, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$165.2M
Net Income (TTM)
-$391.5M
EPS (TTM)
-$9.75
ROA (TTM)
-13.77%
Current Ratio
10.95

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+26.7%Q1 2026-$2.44
+17.1%Q2 2026-$2.29
+3.8%Q3 2026-$2.56
Next

Nov 11

in 62 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About GRAIL Inc.

GRAIL Inc. (NASDAQ: GRAL) develops blood-based cancer detection and related services in the healthcare diagnostics and research business. In FY2025, the company generated $147.2 million in revenue. Its core offerings span population screening, diagnostic support, and research services tied to precision oncology.

Name
GRAIL Inc.
CEO
Joshua J. Ofman
Website
www.grail.com
Industry
Healthcare
Year Founded
2015
Employees
910

Today's Snapshot

AI-generated

Yesterday GRAL fell 2.0% to 77.48.

Trading Volume

Above 10d avg 531.1K

590.2K

vs S&P 500 Today

Underperforming Market

-1.57%

Updated: September 10, 2026 at 12:11 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
GRAL shows a constructive intermediate picture driven by a above-threshold ADX reading that points to a meaningful trend while momentum is mixed, with RSI near neutral and short-term momentum negative. Price sits below the very short moving averages but comfortably above the 200-day average, suggesting medium- and long-term support despite near-term weakness. Volume-based OBV supports the buy stance even as volatility, measured by ATR, is elevated at a mid-single-digit percent, and the pivot sits above the current price. Technical takeaway: indicators collectively favor a buy bias amid short-term churn and higher volatility.
All signals
  • EMA (5 indicators)$70.04 - $78.99
    Buy
  • RSI (14)52.40
    Neutral
  • Stochastic %K (14, 3, 3)51.37
    Neutral
  • MACD Level (12, 26)2.36
    Neutral

Peers & Related Assets

APGEApogee Therapeutics, Inc.
$135.07-0.0%
XENEXenon Pharmaceuticals Inc.
$58.98-1.0%
CELCCelcuity Inc.
$90.08-3.2%
NVSTEnvista Holdings Corp
$26.42-1.4%
IDYAIDEAYA Biosciences, Inc.
$38.35-1.3%
DYNDyne Therapeutics, Inc.
$19.19-5.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.